CELG News Alert Celgene Corp (CELG) 105.75 11/05/2014 05:08:

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Celgene Corp (CELG) 105.75 $CELG

These 5 Drugmakers' Earnings Excelled This Quarter
at Investor's Business Daily - Tue Nov 04, 7:14PM CST
Big pharma firms such as Alexion Pharmaceuticals and Biogen Idec continue to outperform the market as they develop and market new treatments to treat long-time targets such as Alzheimer's as well as rare illnesses. Today's Screen Of The Day is Big...
AGN: 195.12 (+1.98), BIIB: 322.06 (+0.81), VRX: 133.61 (+0.76), ACT: 245.32 (-2.18), JAZZ: 168.48 (-1.85), ALXN: 191.30 (+0.26), CELG: 105.75 (-1.66)

Top Funds Buy Ulta Beauty, Alexion, Avago
at Investor's Business Daily - Tue Nov 04, 5:52PM CST
Managers of leading mutual funds in recent months have continued to stock up on large medical stocks, such as Illumina (ILMN), Alexion Pharmaceuticals (ALXN), Celgene (CELG), Jazz Pharmaceuticals (JAZZ),Allergan (AGN) and Centene (CNC). The...
AMBA: 45.48 (-2.08), MNST: 100.04 (-1.19), SWKS: 60.42 (+0.19), GMCR: 152.11 (+0.21), ILMN: 191.41 (-2.92), WSM: 64.33 (-0.63), NXPI: 69.67 (+0.42), CELG: 105.75 (-1.66), HAIN: 106.79 (-1.55), AGN: 195.12 (+1.98), CNC: 92.04 (+0.47), V: 242.97 (+1.43), CALM: 43.15 (-0.17), JAZZ: 168.48 (-1.85), ALXN: 191.30 (+0.26), LOW: 57.26 (-0.19), ULTA: 120.11 (+0.20), MA: 83.99 (-0.14), AVGO: 85.36 (-0.98), PETM: 70.70 (-1.00)

Final Glance: Biotechnology companies
AP - Tue Nov 04, 5:02PM CST
NEW YORK (AP) — Shares of some top biotechnology companies were mixed at the close of trading:
GILD: 109.72 (-0.26), AMGN: 160.41 (-1.15), CELG: 105.75 (-1.66)

Next Support Level for Celgene (CELG) is $105.49
Comtex SmarTrend(R) - Tue Nov 04, 12:59PM CST
Shares of Celgene (NASDAQ:CELG) have bearishly opened below the pivot of $107.01 today and have reached the first support level of $106.45. Should the shares continue to fall, the support pivots of $105.49 and $103.97 will be of interest.
CELG: 105.75 (-1.66)

Midday Glance: Biotechnology companies
AP - Tue Nov 04, 12:22PM CST
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 1 p.m.:
GILD: 109.72 (-0.26), AMGN: 160.41 (-1.15), CELG: 105.75 (-1.66)

Early Glance: Biotechnology companies
AP - Tue Nov 04, 9:49AM CST
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 10 a.m.:
GILD: 109.72 (-0.26), AMGN: 160.41 (-1.15), CELG: 105.75 (-1.66)

'Mad Money' Lightning Round: I'm Not Crazy About Sysco Anymore
at The Street - Tue Nov 04, 5:00AM CST
Cramer thinks Celgene is a monster stock, says Aramark is a great company and prefers Kinder Morgan over Linn Energy.
KMI: 37.46 (-1.04), ARMK: 28.23 (+0.27), SYY: 37.36 (-0.13), OHI: 38.18 (-0.07), LINE: 23.11 (-1.79), VTR: 69.13 (+0.38), CSCO: 24.88 (+0.30), FEIC: 84.20 (+0.61), EGHT: 7.71 (-0.02), CELG: 105.75 (-1.66)

Jim Cramer's 'Mad Money' Recap: Merger Monday Has Returned
at The Street - Mon Nov 03, 7:14PM CST
LabCorp buying Covance is a win-win for investors, Cramer says.
HYH: 36.97 (-1.48), KMI: 37.46 (-1.04), FB: 75.76 (+1.88), KMB: 113.16 (+1.80), SYY: 37.36 (-0.13), GOOG: 554.11 (-1.11), WM: 48.34 (-0.27), VTR: 69.13 (+0.38), CELG: 105.75 (-1.66), CVD: 100.80 (+0.23), FEIC: 84.20 (+0.61), ARMK: 28.23 (+0.27), SAPE: 24.66 (+0.06), OHI: 38.18 (-0.07), LH: 102.38 (+1.15), LINE: 23.11 (-1.79), TWTR: 40.90 (+0.69), CSCO: 24.88 (+0.30), BABA: 106.07 (+4.27), EGHT: 7.71 (-0.02)

Big Cap 20: Health Care, Tech Stocks Rule The Roost
at Investor's Business Daily - Mon Nov 03, 4:58PM CST
Large-cap stocks often get labeled as boring because of overall sluggish price action, but the latest IBD Big Cap 20 list of leading large-cap growth is far from boring. Recent health care-related names like Alexion Pharmaceuticals (ALXN), Illumina...
LNKD: 238.43 (+5.35), ALXN: 191.30 (+0.26), ILMN: 191.41 (-2.92), REGN: 372.39 (-22.87), CRM: 63.57 (-0.02), CELG: 105.75 (-1.66)

Cramer Sees HP Entering Sector as Trouble for 3-D Printing Stocks
at The Street - Mon Nov 03, 10:57AM CST
Even though HP won't start shipping its 3-D printing machines in bulk until 2016, it could be a problem for other 3-D printing companies.
BMRN: 83.46 (-1.12), ISIS: 45.60 (-0.33), SGEN: 36.57 (-0.68), GILD: 109.72 (-0.26), SSYS: 121.25 (-1.32), HP: 80.69 (-3.60), REGN: 372.39 (-22.87), CELG: 105.75 (-1.66)

'Fast Money' Recap: Will Japan's Stimulus Lead to U.S. Deflation?
at The Street - Sat Nov 01, 4:00AM CDT
The trading panel discussed the S&P 500, whether to buy Apple and if Kim Kardasian is the only thing Glu Mobile has going for it.
FDX: 166.96 (-0.24), HD: 95.96 (-0.13), C: 53.19 (-0.28), SNE: 20.01 (-0.15), BBY: 34.36 (-0.05), GLUU: 3.81 (-0.18), CELG: 105.75 (-1.66), DXJ: 53.51 (-1.52), SBUX: 76.71 (+0.61), GS: 190.27 (-0.56), EXPE: 83.89 (-2.04), AAPL: 108.60 (-0.80), CTRL: 14.93 (-0.66)

IBD 50 Caps Impressive 2-Week Rally
at Investor's Business Daily - Fri Oct 31, 5:47PM CDT
The IBD 50 just capped its best two-week performance in more than three years -- a run that's produced a batch of breakouts. The index rallied 9.4% over the past two weeks. That's the best two-week period since July 2011, when the IBD 50 roared...
ODFL: 74.65 (+1.07), AAP: 148.44 (+0.68), AKRX: 42.64 (-1.18), ILMN: 191.41 (-2.92), NXPI: 69.67 (+0.42), CDW: 31.04 (-0.02), CELG: 105.75 (-1.66), BIDU: 241.96 (+5.42), GILD: 109.72 (-0.26), JAZZ: 168.48 (-1.85), FLT: 148.53 (-1.70), FL: 53.63 (-2.54), AAPL: 108.60 (-0.80), AVGO: 85.36 (-0.98)

Celgene Corporation to Webcast at Upcoming Investor Conferences and Medical Congress
Business Wire - Fri Oct 31, 7:30AM CDT
Celgene Corporation (NASDAQ:CELG) plans to present at two upcoming investor conferences, where Celgene management will provide an overview of the Company, and at the 56th American Society of Hematology (ASH) annual meeting in December. The conferences and ASH event will be webcast live and the webcast will be available in the Investor Relations section of the Company's website at www.celgene.com.
CELG: 105.75 (-1.66), CELGZ: 3.62 (+0.02)

Jim Cramer's Top Stock Picks: CELG REGN GILD BIIB TTWO CRL FLEX
at The Street - Fri Oct 31, 5:00AM CDT
Cramer says Take-Two Interactive is king of the hill and he's a big fan of Flextronics and its stock buyback program.
FLEX: 10.79 (+0.01), TTWO: 25.92 (+0.09), BIIB: 322.06 (+0.81), GILD: 109.72 (-0.26), CRL: 64.12 (-0.31), REGN: 372.39 (-22.87), CELG: 105.75 (-1.66)

Jim Cramer's 'Mad Money' Recap: Here's Why the Bears Were Dead Wrong
at The Street - Thu Oct 30, 7:11PM CDT
The end of quantitative easing was supposed to create a laundry list of problems, Cramer says. It didn't happen.
MMM: 155.05 (+1.75), BIIB: 322.06 (+0.81), HON: 95.29 (-0.37), FB: 75.76 (+1.88), BMY: 57.84 (+0.04), MGM: 22.33 (-0.69), ATK: 112.87 (-4.20), YRCW: 22.90 (+0.61), UPS: 107.08 (+1.44), SLB: 94.16 (-2.36), CELG: 105.75 (-1.66), WPRT: 5.82 (-0.15), SBUX: 76.71 (+0.61), TTWO: 25.92 (+0.09), DO: 33.50 (-1.22), ETP: 63.24 (-1.16), GILD: 109.72 (-0.26), ARR: 3.93 (-0.03), CMG: 647.68 (+9.15), MPEL: 25.47 (-1.10), WNC: 10.30 (+0.16), CRL: 64.12 (-0.31), AAPL: 108.60 (-0.80), REGN: 372.39 (-22.87)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

HTX's Strategic Moves in Pakistan: A Crypto Frontier

Updated Category News Views 6

Paving the Way: HTX's Journey in Pakistan Rolling into the Pakistan cryptocurrency scene isn't just a 'walk in the park' for HTX—it's more like traversing a new frontier with an open map. This isn’t some hit-and-run operation; HTX is strategizing for a long haul in one of the liveliest digital market arenas in South Asia. Gathering steam with community AMAs and an X...

Continue Reading
Anecdotes by Artists Brings Raw Scent Stories to Sephora

Updated Category News Views 2

When Maesa pulls back the curtain, they don't just crack it open—they fling it aside with flair. That's precisely what they're doing with their latest venture, Anecdotes by Artists, a fragrance brand that's taking its first bow exclusively at Sephora. It's not your average perfume launch; it's about the stories behind the scents and the artists who craft them. Unveiling...

Continue Reading
The Chemical Industry and EPA: A Broken System?

Updated Category News Views 6

Decades of an Unchecked Revolving Door The Environmental Protection Agency (EPA) and chemical manufacturers—a dance that’s been going on for what seems like forever. But not in the way you might hope. We're talking about a revolving door where execs and lobbyists waltz into regulatory chairs while regulators slide into cushy industry gigs. Wisner Baum LLP, a stickler...

Continue Reading
Cracking the Code of America's Delivery Addiction

Updated Category News Views 4

America's New Obsession: Convenience at a Cost Diving into the relentless hustle, Americans are shelling out big bucks to dodge life's mundane chores. A fresh survey dished out by FinanceBuzz, hitching a ride with Bank of America, gives us a peek into how hooked everyone is on convenience services like food and grocery deliveries. It’s clear people are ready to fork...

Continue Reading
Succession Planning in Turmoil: Only 42% Ready

Updated Category News Views 5

Diving into the Succession Crisis in Finance Succession planning in the financial advisory space is like retirement planning for the rest of us—everyone knows it's crucial, yet too many put it off. Despite the looming retirement wave and desperate interest from the younger cohort, a staggering 42% of financial advisors are still without a documented succession game...

Continue Reading
FJBio Boosts Antibody Discovery with Sapio AI

Updated Category News Views 5

In the sprawling world of antibody discovery, where every scrap of data can make or break the next big breakthrough, FairJourney Bio (FJBio) is pulling out all the stops. They've teamed up with Sapio Sciences to ditch the paperwork nightmares and usher in a new era of AI-driven efficiency. With operations stretching from Porto to Cambridge to sunny San Diego, they’re...

Continue Reading
K-Beauty Takes Front Stage at Target Beauty Studio

Updated Category News Views 5

Making Waves in the U.S. with K-Beauty SUNGBOON EDITOR and Milk Touch just rolled into Target Beauty Studio, making a splash in the world of K-beauty. From ingredients that boast serious benefits to playful cosmetics that let you express yourself, these brands are shaking up American beauty routines in a big way. Ingredient-Focused Skincare for Every American Face...

Continue Reading
Dr. Desi Bartlett Teams Up with Glo for Perimenopause Focus

Updated Category News Views 4

Glo Taps Top Wellness Expert for Women's Health Initiative In an industry brimming with wellness voices, it's rare to find one that marries scholarly acumen with authentic, personal teaching. Yet, this is precisely what Dr. Desi Bartlett brings to the table as she partners with Glo to offer new fitness programming specifically targeting women facing perimenopause and...

Continue Reading
Sean Trahan Joins Citrin Cooperman: New Tax Lead

Updated Category News Views 7

Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...

Continue Reading
FutureVault's AI Agents: Transforming Financial Workflows

Updated Category News Views 4

Revolutionizing Financial Operations: FutureVault's AI Approach In the dizzying whirlwind of financial services, the launch of FutureVault AI Agents is a game-changer for document management. This isn't some half-baked tool; it's a full-fledged overhaul of how compliance and operations should tick in the modern age. We've all seen it—a paper trail tangled across systems...

Continue Reading

Top 5 Most Recently Viewed Articles

Ascendis Pharma Reports Q2 2024 Results and Positive Outlook

Updated Category News Views 78

Ascendis Pharma Reports Mixed Q2 Results Ascendis Pharma A/S (NASDAQ: ASND) has unveiled its financial results for the second quarter of 2024, revealing a mix of achievements and hurdles. A significant highlight of this quarter was the U.S. approval of YORVIPATH for the treatment of adult hypoparathyroidism. This marks a major milestone as it represents the company's...

Continue Reading
Analyzing New Zealand's Economic Growth and Monetary Policy Shifts

Updated Category News Views 135

New Zealand’s Economic Growth Overview New Zealand's latest growth figures present a significant turning point for a nation that has been adjusting to the impacts of substantial monetary easing. The economy showed a quarterly expansion of 1.1%, bouncing back after a contraction of 1.0% previously. This growth not only exceeded expectations, which were around 0.9%, but...

Continue Reading
Eli Lilly's Competitive Landscape in the Pharmaceuticals Sector

Updated Category News Views 688

Exploring Eli Lilly's Impact on the Pharmaceuticals Sector In the dynamic and competitive world of pharmaceuticals, understanding the role of companies like Eli Lilly & Co. (NYSE: LLY) is crucial for investors and stakeholders alike. This article offers a detailed comparative analysis of Eli Lilly's performance against its main competitors, focusing on key financial...

Continue Reading
Veriff Welcomes Tech Visionary Ott Kaukver to Its Board

Updated Category News Views 165

Veriff Expands Its Board with Industry Expertise Veriff, an innovative identity verification company known for its AI-native technology, recently appointed Ott Kaukver to its Board of Directors. This significant move illustrates the company’s determination to enhance trust in online identities globally. Kaukver, recognized for his role as the former CTO of Twilio and...

Continue Reading
University of Phoenix's New Initiative Promotes Responsible AI Use

Updated Category News Views 154

University of Phoenix Launches Center for AI Resources University of Phoenix has taken a significant step towards empowering its students and faculty by launching the Center for AI Resources. This initiative is designed to equip learners with essential knowledge for navigating the increasingly complex landscape of generative AI (GenAI). The Center serves as a...

Continue Reading